Methods
This is a cross-sectional analytical and descriptive study that included 4324 pregnant women (4366 fetuses, included singleton and twin) referred for FE from 2014 to 2022. The study was conducted at the Health world hospitals and its outreach clinics and camps conducted for fetal echocardiography. Almost 20% of cases were referred from outreach clinic to our center. Detailed history was taken from all pregnant mothers which included maternal age, obstetric history, gestational age (GA), parity, abortions, still births, assisted reproductive technology like In vitro fertilization(IVF)), and family history of CHD (maternal CHD, other sibling with CHD), chromosomal or other congenital anomalies. Prenatal risk factors were extracted
(maternal medical illnesses, infections, medications). Indications for referral, anomaly scan report and fetal echocardiography diagnosis were reported. Neonatal echocardiography was done for confirmation of FE report, also the management plan and outcome of cardiac anomalies were noted.